Top Markets
#1 Prom Prom +36.36%
#2 QuantixAI QuantixAI +31.15%
#3 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +29.68%
#4 MowCat MowCat +27.67%
#5 Pons Pons +22.01%
#6 UnifAI Network UnifAI Network +21.22%
#7 Tutorial Tutorial +20.98%
#8 Versatize Coin Versatize Coin +16.67%
#9 Derive Derive +12.73%
#10 StonkBroker StonkBroker +12.58%
Coin of the day
Prom Prom
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Bioceltix S.a. Bioceltix S.a.

Bioceltix S.a.

BCX
Classifica tra le azioni #20646
Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals... Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals for veterinary use. The company’s products include BCX-CM-J, a stem-cell based biological drug for the treatment of osteoarthritis in dogs; BCX-CM-AD, a drug candidate based on allogeneic stem cells for the treatment of atopic dermatitis in dogs; and BCX-EM, a drug candidate based on allogeneic mesenchymal stem cells for the treatment of arthritis in horses. The company was founded in 2016 and is headquartered in Wroclaw, Poland.
Prezzo delle azioni
$22.66
Capitalizzazione di mercato
$125.37M
Variazione (1 giorno)
0.63%
Variazione (1 anno)
-21.46%
Paese
PL
Scambia Bioceltix S.a. (BCX)

Categoria

Healthcare
Storico del rendimento da dividendi per Bioceltix S.a. (BCX)
Il rendimento da dividendi (TTM) di Bioceltix S.a. (simbolo azionario: BCX) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per Bioceltix S.a. (BCX) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
Azienda Rendimento da dividendi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH